paper
demonstr
infect
cell
cultur
arenaviru
junv
agent
argentin
haemorrhag
fever
lead
activ
signal
pathway
phosphoryl
akt
occur
earli
junv
infect
vero
cell
block
inhibitor
infect
cell
uvirradi
junv
redeem
pattern
stimul
observ
infecti
viru
indic
earli
stage
multipl
cycl
would
enough
trigger
activ
treatment
cell
chlorpromazin
abrog
phosphoryl
akt
upon
junv
infect
suggest
viru
intern
respons
activ
inhibit
akt
phosphoryl
impair
viral
protein
synthesi
express
lead
reduc
infecti
viru
yield
without
block
onset
persist
stage
infect
impair
link
reduc
amount
viru
bound
cell
probabl
due
blockag
recycl
transferrin
cellreceptor
employ
viru
adsorb
cell
surfac
earli
akt
activ
also
observ
junv
infect
cell
suggest
import
role
signal
junv
multipl
vitro
elsevi
bv
right
reserv
viru
junv
agent
argentin
haemorrhag
fever
belong
arenavirida
famili
group
envelop
virus
genom
compos
two
negativesens
singl
strand
rna
segment
l
encod
gene
viral
protein
n
l
gpc
z
use
ambisens
code
strategi
buchmeier
meyer
et
al
previou
find
suggest
arenaviru
pathogenesi
could
well
involv
dysregul
cytokin
immun
signal
control
initi
respons
activ
seri
phosphoryl
event
bowick
et
al
howev
well
understood
arenavirus
induc
cellsignal
chang
lead
dysregul
potenti
clinic
diseas
mani
virus
evolv
mechan
gain
control
key
cellular
signal
pathway
affect
broad
aspect
cellular
macromolecular
synthesi
metabol
growth
surviv
phosphatidylinositol
protein
kinas
b
akt
one
pathway
promot
cell
surviv
phosphoryl
inhibit
number
proapoptot
protein
dna
rna
virus
must
regul
pathway
either
activ
inactiv
aspect
order
achiev
effici
replic
process
cooray
buchkovich
et
al
studi
examin
role
signal
pathway
junv
vitro
infect
first
place
test
whether
junv
infect
would
lead
activ
path
correspond
author
tel
fax
email
address
luisco
qbfcenubaar
la
scolaro
way
examin
kinet
akt
phosphoryl
end
vero
cell
infect
junv
strain
incub
c
min
cultur
process
western
blot
wb
later
sampl
min
pi
viru
remov
min
viruscel
contact
serum
free
medium
ad
cultur
time
zero
postinfect
pi
correspond
inocul
time
point
protein
wholecel
lysat
separ
sdspage
transfer
onto
pvdf
membran
previous
describ
ellenberg
et
al
reveal
use
antiphosphoakt
antibodi
membran
strip
reprob
antiakt
total
antibodi
assur
equal
protein
load
seen
fig
infect
junv
induc
earli
akt
activ
peak
min
pi
sustain
thereaft
moder
level
phosphoryl
min
pi
decreas
min
pi
level
phosphoryl
akt
infect
cell
show
faint
band
slightli
darker
mock
infect
control
fig
b
similar
result
obtain
junv
infect
cell
fig
taken
consider
akt
activ
earli
event
infect
specul
activ
might
due
initi
virushost
cell
interact
test
hypothesi
inocul
vero
cell
condit
describ
uvirradi
junv
prepar
expos
infecti
viru
suspend
pb
w
uv
light
distanc
cm
min
inactiv
viru
infer
fact
vero
cell
infect
uvinactiv
junv
abl
express
process
wb
indic
time
pi
vero
cell
treat
f
infect
junv
moi
pfucel
process
wb
min
pi
phosphoryl
akt
determin
wb
wholecel
lysat
use
phosphoakt
cst
new
england
biolab
total
akt
cst
new
england
biolab
antibodi
fold
chang
akt
phosphoryl
express
densitometr
unit
scion
imag
softwar
band
normal
total
akt
level
rel
uninfect
control
panel
experi
perform
h
serum
starv
cell
infect
treatment
carri
serum
free
medium
viral
protein
detect
wb
fail
yield
infecti
viru
quantifi
plaqu
assay
data
shown
seen
fig
uvirradi
junv
also
led
earli
akt
phosphoryl
event
occur
min
pi
level
stimul
compar
obtain
control
viru
fig
suggest
earli
step
junv
multipl
would
respons
akt
activ
activ
akt
initi
virushost
cell
interact
also
describ
hiv
briand
et
al
enteroviru
wong
et
al
consist
fact
analyz
activ
akt
transferrin
tf
ligand
receptor
employ
junv
enter
mani
cell
type
flanagan
et
al
radoshitzki
et
al
similar
kinet
akt
activ
observ
data
shown
moreov
pattern
akt
activ
induc
junv
tf
also
report
interact
insulinlik
growth
factor
type
receptor
igfir
ligand
previou
report
show
receptor
coloc
tf
receptor
endosom
recycl
similar
fashion
depend
sustain
time
fact
level
phosporyl
akt
junv
infect
cell
analyz
later
time
pi
h
pi
differ
noninfect
cultur
prompt
us
conclud
activ
pathway
depend
junv
protein
synthesi
data
shown
taken
consider
endocyt
uptak
also
earli
event
viru
cycl
activ
pathway
link
entri
ebola
viru
saeed
et
al
rhinoviru
lau
et
al
investig
whether
mechan
might
respons
akt
activ
junv
enter
cell
employ
receptormedi
endocytosi
mechan
involv
clathrin
particip
martinez
et
al
end
test
effect
chlorpromazin
inhibitor
clathrinmedi
endocythosi
akt
phosphoryl
induc
junv
infect
seen
fig
treatment
vero
cell
chlorpromazin
abolish
akt
phosphoryl
induc
junv
infect
strongli
suggest
entri
viru
cell
respons
observ
activ
discard
direct
effect
drug
akt
phosphoryl
insulin
ligand
activ
akt
direct
bind
receptor
use
control
treatment
cell
chlorpromazin
impair
akt
activ
induc
insulin
indic
insulin
treat
cell
abl
activ
pathway
presenc
drug
fig
effect
observ
chlorpromazin
treat
junv
infect
cell
accord
blockag
akt
phosphoryl
observ
intern
igfir
impair
treatment
cell
dansylcadaverin
inhibitor
clathrinmedi
endocythosi
romanelli
et
al
view
akt
constitut
major
downstream
effector
next
analyz
phosphoryl
akt
induc
junv
presenc
specif
inhibitor
purpos
vero
cell
infect
junv
presenc
process
wb
min
pi
determin
phosphoryl
akt
seen
fig
treatment
cell
inhibit
junv
induc
phosphoryl
akt
without
affect
level
express
total
akt
suggest
activ
mediat
also
determin
whether
effect
cellspecif
phenomenon
purpos
akt
activ
effect
viru
multipl
analyz
cell
junv
infect
cell
type
led
earli
akt
activ
similar
manner
describ
vero
cell
peak
case
min
pi
data
shown
investig
whether
activ
akt
junv
play
role
viru
replic
examin
effect
specif
inhibitor
viru
product
vero
cell
seen
fig
viru
infect
recov
junvinfect
cell
treat
reduc
comparison
control
sampl
fact
vero
infect
cultur
treat
compound
show
fivefold
decreas
viru
titer
fig
cell
viabil
cell
type
similar
untreat
cultur
data
shown
consist
result
obtain
effect
inhibit
viral
protein
synthesi
express
analyz
wb
indirect
immunofluoresc
assay
ifa
respect
junv
infect
cell
treat
inhibitor
collect
h
pi
subject
wb
reveal
antin
mab
sanchez
et
al
altern
cell
grown
coverslip
treat
condit
mention
fix
methanol
min
c
process
ifa
previous
describ
ellenberg
et
al
employ
antin
mab
sanchez
et
al
shown
fig
treatment
infect
cell
led
inhibit
n
express
detect
ifa
reach
inhibit
vero
cell
respect
note
although
n
fluoresc
pattern
treat
cell
remain
unchang
proport
fluoresc
intens
posit
cell
markedli
reduc
compar
untreat
control
cell
similarli
seen
fig
inhibit
n
synthesi
detect
wb
accord
result
mention
also
presenc
junv
infect
cell
reduc
synthesi
express
n
suggest
phenomenon
depend
cell
origin
data
shown
result
indic
particip
pathway
junv
multipl
confirm
dominantneg
mutant
akt
employ
murga
et
al
seen
fig
junv
infect
vero
cell
previous
transfect
pcefl
vector
encod
wildtyp
akt
pkbwt
show
higher
proport
cell
bear
green
akt
red
n
fluoresc
comparison
infect
cell
transfect
kinaseinact
mutant
akt
pkbkd
show
reduc
percentag
cell
bear
fluoresc
mark
p
suggest
dominantneg
mutant
akt
impair
n
synthesi
situat
also
lead
reduc
viral
yield
infect
cell
previous
transfect
dominantneg
mutant
fig
contrari
vesicular
stomat
viru
multipl
affect
dominantneg
mutant
accord
previou
result
demonstr
viru
affect
saeed
et
al
addit
differ
time
pi
junv
multipl
cycl
show
inhibit
exert
earli
time
infect
lose
effect
ad
h
pi
fig
indic
requir
activ
junv
multipl
cycl
restrict
earli
stage
infect
confirm
initi
step
multipl
cycl
studi
combin
assay
end
vero
cell
infect
junv
presenc
incub
c
order
allow
adsorpt
penetr
uncoat
virion
differ
incub
time
cell
wash
cold
pb
lyse
freezethaw
infect
quantifi
plaqu
assay
seen
fig
maximum
valu
intern
infect
observ
min
postcontact
treat
untreat
cell
well
follow
decreas
time
cours
depend
manner
case
result
indic
uncoat
occur
control
treat
cell
similar
rate
howev
amount
cellassoci
viru
significantli
lower
case
cell
treat
suggest
impair
uptak
viru
treat
cell
mention
consid
junv
use
transferrin
receptor
adsorb
cell
blockag
recycl
transferrin
receptor
caus
might
account
diminish
level
cell
associ
viru
fact
noninfect
vero
cell
incorpor
label
transferrin
accumul
min
contact
around
nucleou
defin
intens
perinuclear
region
wherea
treat
cultur
show
low
intens
punctuat
pattern
scatter
cytoplasm
fig
result
allow
us
specul
impair
junv
adsorpt
vero
cell
treat
might
due
blockag
transferrin
receptor
recycl
test
hypothesi
vero
cell
treat
incub
transferrin
order
obtain
cell
surfac
deplet
transferrin
receptor
infect
junv
seen
fig
signific
reduct
viru
titer
observ
treat
cell
incub
transferrin
suggest
recycl
transferrin
receptor
necessari
optim
viru
bind
cell
treatment
cultur
per
se
affect
bind
junv
vero
cell
fig
find
may
explain
fact
infect
carri
low
moi
would
enough
presenc
one
cellreceptor
allow
viru
adsorpt
paper
demonstr
junv
infect
cell
cultur
abl
activ
signal
pathway
earli
stage
infect
activ
mediat
viru
intern
would
necessari
effici
viral
multipl
particularli
viru
adsorpt
cell
mediat
transferrin
receptor
direct
effect
akt
phosporyl
inhibit
mediat
gtpase
known
regul
earli
endosom
fusion
li
et
al
discard
howev
observ
junv
abl
uncoat
treat
cell
support
idea
view
report
sarscov
activ
necessari
viru
multipl
acut
infect
establish
persist
well
mizutani
et
al
consid
junv
abl
establish
persist
infect
major
cell
line
infect
decid
analyz
effect
establish
type
infect
observ
impair
viral
multipl
affect
establish
persist
reduc
proport
infect
cell
remain
two
week
treatment
led
establish
persist
infect
cultur
character
continu
synthesi
n
reduc
level
infect
suggest
drug
abl
modifi
transit
acut
persist
infect
data
shown
remain
elucid
role
akt
mainten
stage
infect
particularli
focus
control
h
pi
supernat
collect
viru
titer
calcul
plaqu
assay
altern
cell
treat
condit
mention
fix
methanol
subject
ifa
b
process
wb
c
determin
n
synthesi
express
valu
b
indic
inhibit
calcul
amount
fluoresc
intens
imageproexpress
softwar
treat
cell
comparison
untreat
control
similar
number
total
cell
analyz
categori
vero
cell
transfect
either
pcefl
vector
encod
wildtyp
akt
pkbwt
kinaseinact
mutant
pkbkd
infect
junv
moi
pfucel
h
posttransfect
fix
h
pi
methanol
ifa
employ
antin
red
fluoresc
antiakt
green
fluoresc
antibodi
valu
merg
panel
indic
cell
bear
color
approx
cell
bear
similar
level
akt
express
score
duplic
coverslip
h
infect
viru
yield
determin
plaqu
assay
vesicular
stomat
viru
vsv
employ
neg
control
e
vero
cell
infect
junv
moi
pfucel
treat
differ
time
pi
incub
h
pi
viru
yield
quantifi
plaqu
assay
f
vero
cell
infect
junv
moi
pfucel
presenc
absenc
incub
c
lyse
freez
thaw
differ
time
postinocul
g
intern
viru
cell
lysat
quantifi
plaqu
assay
vero
cell
treat
incub
tritclabel
transferrin
sigma
process
ifa
min
postcontact
h
vero
cell
previous
incub
gml
transferrin
tf
ly
transferrin
ly
tf
infect
approx
pfu
junv
overlay
plaqu
medium
experi
n
perform
h
serum
starv
cultur
infect
andor
treatment
carri
serum
free
medium
viru
replic
account
superinfect
exclus
phenomenon
observ
homolog
junv
antigen
relat
virus
ellenberg
et
al
restrict
due
least
part
enhanc
express
protein
involv
vacuolar
protein
sort
machineri
prevent
bud
junv
persist
infect
cell
ellenberg
et
al
taken
consider
regul
akt
phophoryl
mayo
donner
turn
ubiquitin
tumor
supress
protein
tag
degrad
lead
antiapoptot
scenario
zhou
et
al
tempt
specul
activ
stabil
pathway
respect
might
critic
defin
fate
junv
multipl
persist
infect
cell
